AU2002231283A1 - Use of p38 inhibitors for the treatment of smoke inhalation - Google Patents
Use of p38 inhibitors for the treatment of smoke inhalationInfo
- Publication number
- AU2002231283A1 AU2002231283A1 AU2002231283A AU3128302A AU2002231283A1 AU 2002231283 A1 AU2002231283 A1 AU 2002231283A1 AU 2002231283 A AU2002231283 A AU 2002231283A AU 3128302 A AU3128302 A AU 3128302A AU 2002231283 A1 AU2002231283 A1 AU 2002231283A1
- Authority
- AU
- Australia
- Prior art keywords
- inhibitors
- treatment
- smoke inhalation
- inhalation
- smoke
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US24156800P | 2000-10-19 | 2000-10-19 | |
US60/241,568 | 2000-10-19 | ||
PCT/US2001/050429 WO2002032862A2 (en) | 2000-10-19 | 2001-10-19 | Use of p38 inhibitors for the treatment of smoke inhalation |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2002231283A1 true AU2002231283A1 (en) | 2002-04-29 |
Family
ID=22911223
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2002231283A Abandoned AU2002231283A1 (en) | 2000-10-19 | 2001-10-19 | Use of p38 inhibitors for the treatment of smoke inhalation |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP1337250A2 (en) |
JP (1) | JP2004511542A (en) |
AU (1) | AU2002231283A1 (en) |
WO (1) | WO2002032862A2 (en) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1709965A3 (en) | 2001-07-11 | 2006-12-27 | Boehringer Ingelheim Pharmaceuticals, Inc. | Methods of treating cytokine mediate diseases |
MXPA04009605A (en) * | 2002-04-05 | 2005-01-11 | Boehringer Ingelheim Pharma | Method of treating mucus hypersecretion. |
JP4895811B2 (en) | 2003-09-11 | 2012-03-14 | ケミア,インコーポレイテッド | Cytokine inhibitor |
WO2006137421A1 (en) * | 2005-06-21 | 2006-12-28 | Kyowa Hakko Kogyo Co., Ltd. | Agent for topical administration |
WO2017151409A1 (en) | 2016-02-29 | 2017-09-08 | University Of Florida Research Foundation, Incorporated | Chemotherapeutic methods |
US10342786B2 (en) | 2017-10-05 | 2019-07-09 | Fulcrum Therapeutics, Inc. | P38 kinase inhibitors reduce DUX4 and downstream gene expression for the treatment of FSHD |
CN114732910A (en) | 2017-10-05 | 2022-07-12 | 弗尔康医疗公司 | P38 kinase inhibitor reduces DUX4 and downstream gene expression for treatment of FSHD |
CN109557254B (en) * | 2018-11-14 | 2021-08-03 | 云南中烟工业有限责任公司 | Method for establishing standardized cigarette smoke mouse mouth and nose exposure method |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2000507545A (en) * | 1996-03-25 | 2000-06-20 | スミスクライン・ビーチャム・コーポレイション | Novel treatment for CNS injury |
AU4429799A (en) * | 1998-06-12 | 1999-12-30 | Vertex Pharmaceuticals Incorporated | Inhibitors of p38 |
-
2001
- 2001-10-19 EP EP01987743A patent/EP1337250A2/en not_active Withdrawn
- 2001-10-19 AU AU2002231283A patent/AU2002231283A1/en not_active Abandoned
- 2001-10-19 WO PCT/US2001/050429 patent/WO2002032862A2/en active Application Filing
- 2001-10-19 JP JP2002536046A patent/JP2004511542A/en active Pending
Also Published As
Publication number | Publication date |
---|---|
JP2004511542A (en) | 2004-04-15 |
EP1337250A2 (en) | 2003-08-27 |
WO2002032862A2 (en) | 2002-04-25 |
WO2002032862A3 (en) | 2002-08-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EG22308A (en) | Tobacco treatment | |
IL196301A0 (en) | Medicament for the treatment of hapatitis c | |
AU2002339157A1 (en) | Inhibitors of the notch signalling pathway for use in the treatment of cancer | |
AU2002258399A1 (en) | Use of trail and antiprogestins for treating cancer | |
ZA200510170B (en) | Method of reducing the harmful effects of orally or transdermally delivered nicotine | |
IL151890A0 (en) | Hydroxyphenyl-piperidin 4-ylidene-methyl-benzamide derivatives for the treatment of pain | |
HK1053058A1 (en) | Use of pramipexole for the treatment of addictive disorders | |
AU2002248269A1 (en) | Use of p38 inhibitors for the treatment of inflammation-enhanced cough | |
IL160853A0 (en) | Nicotine containing formulations and use thereof | |
AU6083899A (en) | Combination of c1-inh and lung surfactant for the treatment of respiratory disorders | |
AU2001285747A1 (en) | Method for the treatment of tobacco | |
AU6900201A (en) | Breath-controlled therapeutic inhalation device | |
GB0004531D0 (en) | The treatment of respiratory diseases | |
HK1083732A1 (en) | Compounds for the treatment of tobacco dependence and withdrawal | |
AU2002220735A1 (en) | Substituted derivatives of aminofuran-2-yl-acetic acid and aminothien-2-yl-acetic acid and the use thereof for treating migraines and pain | |
AU2001293891A1 (en) | New combination for the treatment of asthma | |
IL151765A0 (en) | Hydroxyphenyl-piperazinyl-methyl-benzamide derivatives for the treatment of pain | |
IL151891A0 (en) | Quinolinyl-piperidin 4-ylidene-methyl-benzamide derivatives for the treatment of pain | |
AU2002231283A1 (en) | Use of p38 inhibitors for the treatment of smoke inhalation | |
AU2001249262A1 (en) | Therapeutic compounds for the treatment of asthma and allergy, and methods of use thereof | |
AU7402201A (en) | Use of substituted 1-amino-5-phenylpentane-3-ol and/or 1-amino-6-phenylhexane-3-ol compounds as medicaments | |
AU2001274022A1 (en) | Use of substituted 1-amino-5-phenylpentane-3-ol and/or 1-amino-6-phenylhexane-3-ol compounds as medicaments | |
AU2001253560A1 (en) | Methods of treatment | |
AU2002221882A1 (en) | Use of 3-hydroxyl-3-methylglutaryl-coenzyme-a-reductase inhibitors | |
AU2908501A (en) | Combination therapy for the treatment of inflammatory and respiratory diseases |